Acyclovir for herpes zoster. 1994

P J van den Broek, and P M Stuyt, and J W van der Meer

UI MeSH Term Description Entries
D006562 Herpes Zoster An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed) Shingles,Zona,Zoster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U
D016867 Immunocompromised Host A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation. Immunosuppressed Host,Immunocompromised Patient,Host, Immunocompromised,Host, Immunosuppressed,Hosts, Immunocompromised,Hosts, Immunosuppressed,Immunocompromised Hosts,Immunocompromised Patients,Immunosuppressed Hosts,Patient, Immunocompromised,Patients, Immunocompromised

Related Publications

P J van den Broek, and P M Stuyt, and J W van der Meer
August 1994, The New England journal of medicine,
P J van den Broek, and P M Stuyt, and J W van der Meer
November 1988, Drug and therapeutics bulletin,
P J van den Broek, and P M Stuyt, and J W van der Meer
September 1984, Lancet (London, England),
P J van den Broek, and P M Stuyt, and J W van der Meer
October 1984, Lancet (London, England),
P J van den Broek, and P M Stuyt, and J W van der Meer
October 1981, Lancet (London, England),
P J van den Broek, and P M Stuyt, and J W van der Meer
April 1989, The New Zealand medical journal,
P J van den Broek, and P M Stuyt, and J W van der Meer
November 1981, The New England journal of medicine,
P J van den Broek, and P M Stuyt, and J W van der Meer
May 1997, Annals of internal medicine,
P J van den Broek, and P M Stuyt, and J W van der Meer
May 1997, Annals of internal medicine,
P J van den Broek, and P M Stuyt, and J W van der Meer
July 1992, Ophthalmology,
Copied contents to your clipboard!